Avacta Group Plc (LON:AVCT – Get Free Report)’s stock price traded up 15.2% during trading on Thursday . The stock traded as high as GBX 53 ($0.67) and last traded at GBX 51.85 ($0.66). 4,413,144 shares traded hands during mid-day trading, an increase of 78% from the average session volume of 2,475,059 shares. The stock had previously closed at GBX 45 ($0.57).
Avacta Group Trading Up 6.7 %
The company’s fifty day moving average is GBX 43.86 and its two-hundred day moving average is GBX 70.53. The company has a quick ratio of 4.96, a current ratio of 0.62 and a debt-to-equity ratio of 191.87. The stock has a market cap of £199.27 million, a price-to-earnings ratio of -616.67 and a beta of 1.22.
Avacta Group Company Profile
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
See Also
- Five stocks we like better than Avacta Group
- Overbought Stocks Explained: Should You Trade Them?
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- Most active stocks: Dollar volume vs share volume
- MarketBeat Week in Review – 6/24 – 6/28
- 10 Best Airline Stocks to Buy
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
